Mitochondrial replacement therapy aims to prevent genetic disorders by transferring mitochondria from a donor egg to one with mutations in the mitochondrial DNA. This technique allows for the inheritance of healthy mitochondrial DNA instead of disease-causing mutations. Preclinical animal studies have shown this therapy to be safe and effective, with donor mitochondrial DNA being passed down to subsequent generations. It represents the first form of germline gene therapy for inherited mitochondrial diseases.